These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33293588)

  • 1. Efficient viral delivery of Cas9 into human safe harbor.
    Hayashi H; Kubo Y; Izumida M; Matsuyama T
    Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing.
    Pedrazzoli E; Demozzi M; Visentin E; Ciciani M; Bonuzzi I; Pezzè L; Lucchetta L; Maule G; Amistadi S; Esposito F; Lupo M; Miccio A; Auricchio A; Casini A; Segata N; Cereseto A
    Nat Commun; 2024 Apr; 15(1):3478. PubMed ID: 38658578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus pre-packed with Cas9 protein for safer gene editing.
    Choi JG; Dang Y; Abraham S; Ma H; Zhang J; Guo H; Cai Y; Mikkelsen JG; Wu H; Shankar P; Manjunath N
    Gene Ther; 2016 Jul; 23(7):627-33. PubMed ID: 27052803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
    Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
    Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
    Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
    Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.
    Lu B; Javidi-Parsijani P; Makani V; Mehraein-Ghomi F; Sarhan WM; Sun D; Yoo KW; Atala ZP; Lyu P; Atala A
    Nucleic Acids Res; 2019 May; 47(8):e44. PubMed ID: 30759231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
    Fry LE; Peddle CF; Stevanovic M; Barnard AR; McClements ME; MacLaren RE
    CRISPR J; 2020 Aug; 3(4):276-283. PubMed ID: 32833533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
    Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
    Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
    Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
    BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.
    Zhang Y; Li H; Min YL; Sanchez-Ortiz E; Huang J; Mireault AA; Shelton JM; Kim J; Mammen PPA; Bassel-Duby R; Olson EN
    Sci Adv; 2020 Feb; 6(8):eaay6812. PubMed ID: 32128412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
    Ryø LB; Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
    Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
    Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
    Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
    Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Disruption Using CRISPR-Cas9 Technology.
    Hu N; Malek SN
    Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated reverse transcriptase enhances prime editing by split AAV vectors.
    Gao Z; Ravendran S; Mikkelsen NS; Haldrup J; Cai H; Ding X; Paludan SR; Thomsen MK; Mikkelsen JG; Bak RO
    Mol Ther; 2022 Sep; 30(9):2942-2951. PubMed ID: 35808824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.